Jacky Luiten

Trends in frequency and outcome of high‐risk breast lesions at CNB |53 4 Table 4.2 Type of mammographic abnormality at screening mammography and type of assessment after recall. Screening year 2011 2012 2013 2014 2015 2016 Total Mammographic abnormality , (%) Suspicious mass Suspicious calcifications Suspicious mass with calcifications Asymmetry Architectural distortion Other 978 (60.7) 390 (24.3) 105 (6.5) 20 (1.2) 117 (7.3) 0 1256 (66.1) 371 (19.5) 81 (4.3) 33 (1.7) 158 (8.3) 0 1728 (72.1) 406 (16.9) 86 (3.6) 36 (1.5) 142 (5.9) 0 1550 (68.7) 315 (14.0) 80 (3.5) 118 (5.2) 192 (8.5) 0 1062 (61.0) 299 (17.2) 67 (3.9) 142 (8.2) 160 (9.2) 10 (0.6) 1060 (56.4) 381 (20.3) 68 (3.6) 234 (12.4) 101 (5.4) 37 (2.0) 7634 (64.8) 2162 (18.3) 487 (4.1) 583 (4.9) 870 (7.4) 47 (0.4) Assessment after recall , (%) None or unknown Imaging Imaging + FNAC Imaging + CNB Imaging + SCNB Imaging + CB + SCNB Imaging + other combinations of percutaneous biopsy Imaging + (S)CNB + diagnostic surgical excision Imaging + diagnostic surgical excision 3 (0.2) 831 (51.6) 38 (2.4) 366 (22.7) 318 (19.8) 22 (1.4) 10 (0.6) 21 (1.3) 1 (0.1) 2 (0.1) 1037 (54.6) 48 (2.5) 426 (22.4) 304 (16.0) 25 (1.3) 24 (1.3) 29 (1.5) 4 (0.2) 1 (0) 1422 (59.3) 42 (1.8) 498 (20.8) 362 (15.1) 24 (1.0) 17 (0.7) 30 (1.3) 2 (0.1) 9 (0.4) 1357 (60.2) 31 (1.4) 502 (22.3) 275 (12.2) 27 (1.2) 9 (0.4) 41 (1.8) 4 (0.2) 3 (0.2) 915 (52.6) 23 (1.3) 472 (27.1) 262 (15.1) 27 (1.6) 7 (0.4) 31 (1.8) 0 (0) 6 (0.3) 974 (51.8) 25 (1.3) 454 (24.1) 311 (16.5) 45 (2.4) 15 (0.8) 51 (2.7) 0 (0) 24 (0.2) 6536 (55.5) 207 (1.8) 2718 (23.1) 1832 (15.5) 170 (1.4) 82 (0.7) 203 (1.7) 11 (0.1) FNAC = fine needle aspiration cytology; CNB = core needle biopsy (14‐18 Gauge); SCNB = stereotactic core needle biopsy (9‐11 Gauge).